Medfinder
Back to blog

Updated: January 18, 2026

Relpax Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Header image for blog post 04: Relpax Shortage Update: What Patients Need to Know in 2026

Is Relpax in shortage in 2026? Get the latest update on eletriptan availability, pricing, and what to do if you can't find it at your pharmacy.

If you've had trouble filling your Relpax (eletriptan) prescription in 2026, you're not imagining things. Many migraine patients across the country are reporting difficulty finding this medication — whether it's the brand-name or the generic — at their usual pharmacies.

So is Relpax officially in shortage? And what should you do? Here's everything you need to know as of 2026.

Official Shortage Status: No FDA Shortage Listed

As of 2026, Relpax (eletriptan hydrobromide) is NOT on the FDA's official drug shortage list. The FDA shortage database tracks medications where demand significantly outpaces manufacturing capacity at a national level. Eletriptan does not currently meet that threshold.

However, the absence of a formal shortage doesn't mean your local pharmacy has it in stock. Availability problems are real — they're just driven by different factors.

Why Patients Are Struggling to Find Relpax

The root causes of Relpax availability problems in 2026 are economic and logistical — not manufacturing failures:

Brand exclusions from formularies: Most major commercial insurers have excluded brand-name Relpax from their 2026 formularies in favor of generic eletriptan. Pharmacies, responding to low demand, reduce their brand Relpax stock.

Market consolidation in generics: While generic eletriptan is approved, the number of active manufacturers is limited. When one manufacturer has a production slowdown or changes distribution, localized shortages can appear at individual pharmacy chains.

Low stocking at chain pharmacies: Eletriptan is a low-volume medication compared to statins, blood pressure drugs, and diabetes medications. Chain pharmacies use predictive algorithms that result in minimal safety stock for low-volume items.

Confusion about brand vs. generic: Many patients ask for "Relpax" when their prescription is actually fillable as generic eletriptan, which is more widely stocked. This creates a communication mismatch.

Is This a Permanent Problem?

Not necessarily. Brand-name Relpax will likely remain harder to find at chain pharmacies as long as insurers exclude it from formularies. However, generic eletriptan is expected to remain available nationally — the difficulty is simply knowing which pharmacy near you has it in stock on any given day.

What Patients Should Do Right Now

Use medfinder: medfinder.com calls pharmacies near you to check stock. You provide your medication info and location, and get results by text.

Ask for generic eletriptan hydrobromide: Many patients get turned away when asking for "Relpax" but would find the generic easily available. They are clinically equivalent.

Try independent pharmacies: Local independent pharmacies are more likely to special-order your medication within 24 hours.

Talk to your doctor about a bridge: If you've been out for several days, ask about a short-term prescription for sumatriptan or rizatriptan while you locate your eletriptan fill.

Refill early: Don't wait until you're out. Refill when you have 1–2 tablets left, giving yourself time to locate stock.

How Does Eletriptan Compare in Effectiveness?

Eletriptan 40mg achieves pain freedom in approximately 37% of patients at 2 hours, the highest of any oral triptan in comparative studies. Pain relief (meaning reduction in pain, not necessarily complete pain freedom) was achieved by 60% at 2 hours — also the highest in its class. This superior efficacy is why patients are willing to go through extra effort to find it.

See our full guide on how to find Relpax in stock near you, or explore alternatives to Relpax if you've been unable to fill for several days.

Frequently Asked Questions

No. As of 2026, Relpax (eletriptan) is not listed on the FDA's official drug shortage database. Availability challenges are driven by pharmacy stocking decisions and insurance formulary exclusions of the brand, not manufacturing shortages.

Chain pharmacies use inventory algorithms that minimize stock for low-volume medications. Since brand Relpax is excluded from most 2026 formularies and generic eletriptan has limited manufacturers, chain pharmacies may not keep it consistently stocked. Independent pharmacies and mail-order options tend to be more reliable.

Generic eletriptan availability is expected to remain stable nationally in 2026. Brand Relpax may remain difficult to find at chain pharmacies due to continued formulary exclusions. The key is knowing which pharmacy near you has stock — which is where tools like medfinder.com can help.

Yes. Generic eletriptan hydrobromide has been FDA-approved and is manufactured by companies including Aurobindo Pharma. It is bioequivalent to brand Relpax and typically costs as low as $24–$25 per 6 tablets (40mg) with a GoodRx or SingleCare coupon.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Relpax also looked for:

30,305 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,305 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?